NHS and NICE announce plan to adopt innovative medical technologies for patients
The proposals will help MedTech developers access NHS funding to fast-track products
Read Moreby Jen Brogan | May 29, 2024 | News | 0
The proposals will help MedTech developers access NHS funding to fast-track products
Read Moreby Jen Brogan | May 10, 2024 | News | 0
The sandbox will help to inform future AI Airlock projects and influence future AlaMD guidance
Read Moreby Jen Brogan | May 2, 2024 | News | 0
The inherited disorder is caused by genetic mutations that affects haemoglobin production
Read Moreby Jen Brogan | Mar 8, 2024 | News | 0
The rare epileptic seizure disorder currently affects around one in 42,000 people in the UK
Read Moreby Jen Brogan | Nov 27, 2023 | News | 0
The IRP will bring life-saving medicines to UK patients from 1 January 2024
Read Moreby Jen Brogan | Oct 27, 2023 | News | 0
The new principles will remove the regulatory burden for MLMD manufacturers
Read Moreby Anna Smith | Mar 5, 2019 | News | 0
A BBC reporter has discovered an online trade of illegal drugs for STIs.
Read Moreby Anna Smith | Feb 22, 2019 | News | 0
The MHRA has issued a drug safety warning for Neo-mercazole in pregnancy, urging women of childbearing potential to use effective contraception during treatment
Read Moreby Anna Smith | Jan 22, 2019 | News | 0
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given formal approval for Redx Pharma to re-commence a Phase I/IIa trial of experimental cancer therapy RXC004.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
